Skip to main content
Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada flag Canada · Delayed Price · Currency is CAD
0.0850
-0.0050 (-5.56%)
Dec 5, 2025, 3:59 PM EST

Revenue by Product

Fiscal year is September - August.
Fiscal Year
 FY 2024 FY 2023 FY 2022
Period Ending
 Aug '24 Aug '23 Aug '22
MDMA and MDXX
722.71K
Log In
Log In
MDMA and MDXX Growth
73.04%
Log In
Log In
License
224.34K
Log In
Log In
License Growth
96.17%
Log In
Log In
Consulting
88.25K
Log In
Log In

Revenue by Geography

Fiscal year is September - August.
Fiscal Year
 FY 2024 FY 2023 FY 2022
Period Ending
 Aug '24 Aug '23 Aug '22
Australia
844.71K
Log In
Log In
Canada
158.21K
Log In
Log In
Canada Growth
-70.26%
Log In
Log In
United States
32.38K
Log In
Log In